Cargando…
Mouse Mammary Tumor Virus Promoter-Containing Retroviral Promoter Conversion Vectors for Gene-Directed Enzyme Prodrug Therapy are Functional In Vitro and In Vivo
Gene directed-enzyme prodrug therapy (GDEPT) is an approach for sensitization of tumor cells to an enzymatically activated, otherwise nontoxic, prodrug. Cytochrome P450 2B1 (CYP2B1) metabolizes the prodrugs cyclophosphamide (CPA) and ifosfamide (IFA) to produce the cytotoxic substances phosphoramide...
Autores principales: | Klein, Reinhard, Ruttkowski, Bärbel, Schwab, Sonja, Peterbauer, Thomas, Salmons, Brian, Günzburg, Walter H., Hohenadl, Christine |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291507/ https://www.ncbi.nlm.nih.gov/pubmed/18414588 http://dx.doi.org/10.1155/2008/683505 |
Ejemplares similares
-
Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors
por: Paar, Matthias, et al.
Publicado: (2009) -
Dual-vector prodrug activator gene therapy using retroviral replicating vectors
por: Kubo, Shuji, et al.
Publicado: (2018) -
Identification of the Rem-responsive element of mouse mammary tumor virus
por: Müllner, Matthias, et al.
Publicado: (2008) -
Rapid spread of mouse mammary tumor virus in cultured human breast cells
por: Indik, Stanislav, et al.
Publicado: (2007) -
Retroviral Replicating Vectors Mediated Prodrug Activator Gene Therapy in a Gastric Cancer Model
por: Fujino, Hiroaki, et al.
Publicado: (2023)